Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV078
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,555
Award facts
- Contract value 100% obligated
- $87,555.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $87,555.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The order, issued on December 30, 2025, with an ultimate completion date of January 22, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The award leverages the company's comprehensive $999,999,999.00 IDC (designated SPE2DX) running through December 2026, which enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order exemplifies AmerisourceBergen's role as a key supplier within the DLA Medical Supply Chain, delivering specialized pharmaceutical products to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. Vyndamax is a branded treatment for transthyretin (TTR) amyloidosis, reflecting the company's extensive portfolio spanning specialty medications, brand-name and generic drugs, and other critical medical commodities. As a child contract under the larger SPE2DX vehicle, this order demonstrates the flexibility and scope of the indefinite delivery framework, which consolidates pharmaceutical procurement across multiple therapeutic domains and geographic regions to support military medical readiness.
Quick answers
Who was awarded contract SPE2DR26FV078?
SPE2DR26FV078 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FV078 worth?
The government has obligated $87,555 on SPE2DR26FV078.
Is contract SPE2DR26FV078 an order under another contract?
Yes. SPE2DR26FV078 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV078 competed?
The extent of competition for SPE2DR26FV078 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award